Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection

Sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04251247
Collaborator
(none)
159
2
24
79.5
3.3

Study Details

Study Description

Brief Summary

Acute aortic dissection is rare but potentially life-threatening disease with an incidence of 5-30 cases per million, annually. Therefore prompt diagnosis is crucial. D-dimer values have been shown to be useful in the diagnosis of acute aortic dissection. Fibrinogen levels have been shown to be low, normal or high in individuals with acute aortic dissection. This study aims to investigate whether D-dimer/fibrinogen ratio can be valuable for diagnosis of acute aortic dissection.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: D-dimer/fibrinogen ratio

Study Design

Study Type:
Observational
Anticipated Enrollment :
159 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Diagnostic Value of D-dimer/Fibrinogen Ratio in Patients With Acute Aortic Dissection
Actual Study Start Date :
Mar 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Mar 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Acute aortic dissection

Patients with a diagnosis of acute aortic dissection.

Diagnostic Test: D-dimer/fibrinogen ratio
The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Acute pulmonary embolism

Patients with a diagnosis of acute pulmonary embolism

Diagnostic Test: D-dimer/fibrinogen ratio
The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Non-cardiac chest pain

Patients with non-cardiac chest pain

Diagnostic Test: D-dimer/fibrinogen ratio
The ratio of D-dimer (ng/ml) to fibrinogen (mg/dl)

Outcome Measures

Primary Outcome Measures

  1. Acute aortic dissection [24 hours]

    Diagnosis of acute aortic dissection confirmed by contrast enhanced computed tomography, magnetic resonance imaging, echocardiography or aortography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of acute aortic dissection

  • Diagnosis of acute pulmonary embolism

  • Diagnosis of non-cardiac chest pain

Exclusion Criteria:
  • Any etiology of chest pain other than acute aortic dissection, acute pulmonary embolism, or non-cardiac chest pain

  • Participants who do not give consent for enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Istanbul Turkey 34668
2 Kartal Dr. Lutfi Kirdar Training and Research Hospital Istanbul Turkey 34890

Sponsors and Collaborators

  • Dr. Lutfi Kirdar Kartal Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ahmet Can Topcu, Director of Department of Cardiovascular Surgery, Dr. Lutfi Kirdar Kartal Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04251247
Other Study ID Numbers:
  • 2020/514/169/B
First Posted:
Jan 31, 2020
Last Update Posted:
Feb 4, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 4, 2021